| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0304-3835(97)00280-2 |
| P698 | PubMed publication ID | 9570376 |
| P2093 | author name string | C Lu | |
| M Matsumura | |||
| T Horiuchi | |||
| R Muraoka | |||
| N Tanigawa | |||
| H Amaya | |||
| T Shimomatsuya | |||
| P2860 | cites work | Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor | Q24294262 |
| The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor | Q24328901 | ||
| Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor | Q28236903 | ||
| Angiogenic factor | Q28306483 | ||
| Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis | Q34210479 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. | Q35823939 | ||
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
| Vascular permeability factor (VPF, VEGF) in tumor biology | Q40801255 | ||
| Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? | Q41672716 | ||
| Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. | Q42805124 | ||
| Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells | Q42830513 | ||
| Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. | Q55075615 | ||
| Microvessel count predicts metastatic disease and survival in non-small cell lung cancer | Q58212432 | ||
| Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity | Q67597921 | ||
| Vascular permeability factor mRNA and protein expression in human kidney | Q67977227 | ||
| Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study | Q68985258 | ||
| Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract | Q69963891 | ||
| Prognostic value of vascular endothelial growth factor expression in gastric carcinoma | Q71018131 | ||
| Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma | Q71396402 | ||
| Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells | Q71396411 | ||
| Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1 | Q71644976 | ||
| Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer | Q71701937 | ||
| Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells | Q71893658 | ||
| Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma | Q71917314 | ||
| Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma | Q71980508 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer | Q72410073 | ||
| Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine | Q72852182 | ||
| Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma | Q73117421 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| cell growth | Q189159 | ||
| angiogenesis | Q539568 | ||
| colorectal carcinoma | Q25493920 | ||
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 227-235 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer | |
| P478 | volume | 119 |
| Q38671965 | A novel antimetabolite: TAS-102 for metastatic colorectal cancer |
| Q36591067 | Antiangiogenic therapy in human gastrointestinal malignancies |
| Q28749488 | Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF |
| Q55495915 | Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysis. |
| Q35165648 | Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches |
| Q36520166 | Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer |
| Q77593531 | Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors |
| Q33354817 | Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer |
| Q79661656 | Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast |
| Q40589399 | Expression of thymidine phosphorylase by macrophages in colorectal cancer tissues |
| Q73674295 | Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma |
| Q58612325 | Genetic variation determines VEGF-A plasma levels in cancer patients |
| Q34457421 | Inhibition of vascular endothelial growth factor in the treatment of solid tumors |
| Q45276627 | Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration |
| Q36614453 | Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature |
| Q35212710 | Molecular prognostics in colorectal cancer |
| Q92364940 | Phage display screening of therapeutic peptide for cancer targeting and therapy |
| Q54542173 | Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer. |
| Q39665887 | Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy |
| Q84792092 | Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma |
| Q43947296 | Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma |
| Q36646148 | Role of biological markers in the clinical outcome of colon cancer |
| Q34980526 | The dual role of thymidine phosphorylase in cancer development and chemotherapy |
| Q46540109 | The prognostic value of c-Kit, K-ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer |
| Q64902371 | Thymidine phosphorylase affects clinical outcome following surgery and mRNA expression levels of four key enzymes for 5-fluorouracil metabolism in patients with stage I and II non-small cell lung cancer. |
| Q73833968 | Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer |
| Q37308766 | Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung |
| Q39092845 | Tumor cell response to bevacizumab single agent therapy in vitro |
| Q33839146 | Tumor markers--prognostic and therapeutic implications for colorectal carcinoma |
| Q36617345 | Tumour markers of prognosis in colorectal cancer |
| Q42864506 | Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors. |
| Q33274369 | Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors |
| Q43202368 | Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer |
Search more.